Bioequivalence of HX575 (recombinant human epoetin alfa) and a comparator epoetin alfa after multiple intravenous administrations: an open-label randomised controlled trial
-
* Corresponding author: Fritz Sörgel ibmp@osn.de
BMC Clinical Pharmacology 2009, 9:10 doi:10.1186/1472-6904-9-10
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 23 Oct 2008 | |
| Reviewer's Report | Anis Khan | 06 Dec 2008 | |
| Reviewer's Report | Larry Gould | 11 Dec 2008 | |
| Reviewer's Report | Amit Garg | 12 Dec 2008 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 24 Feb 2009 |
| Reviewer's Report | Larry Gould | 12 Mar 2009 | |
| Reviewer's Report | Anis Khan | 17 Mar 2009 | |
| Reviewer's Report | Amit Garg | 23 Mar 2009 | |
| Editorial acceptance | 20 Apr 2009 | ||
| Published | 22 May 2009 |